Irinotecan plus temozolomide for pediatric relapsed or refractory solid tumors: a retrospective cohort study
Translational Pediatrics · 2026-06 · 15 (6) · 210-210
DOI: 10.21037/tp-2026-0280 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Translational Pediatrics, 2026-06. Verfasst von Jianming Fang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Solid Tumors, Beijing Jingdu Children's Hospital, Beijing, China. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology and Solid Tumors, Beijing Jingdu Children's Hospital, Beijing, China.
Zitieren
APA
Fang, J., Zhang, Y., Liu, Q., Dong, Z., Gong, H., Zhou, W., Wang, Y., & Liu, H. (2026). Irinotecan plus temozolomide for pediatric relapsed or refractory solid tumors: a retrospective cohort study. Translational Pediatrics, 15(6), 210-210. https://doi.org/10.21037/tp-2026-0280
Vancouver
Fang J, Zhang Y, Liu Q, Dong Z, Gong H, Zhou W, et al. Irinotecan plus temozolomide for pediatric relapsed or refractory solid tumors: a retrospective cohort study. Translational Pediatrics. 2026;15(6):210-210. doi:10.21037/tp-2026-0280
BibTeX
@article{Fang2026,
author = {Fang, Jianming and Zhang, Yingli and Liu, Qi and Dong, Zeyu and Gong, Han and Zhou, Wei and Wang, Yuchi and Liu, Hongyan},
title = {Irinotecan plus temozolomide for pediatric relapsed or refractory solid tumors: a retrospective cohort study},
journal = {Translational Pediatrics},
year = {2026},
volume = {15},
number = {6},
pages = {210--210},
doi = {10.21037/tp-2026-0280}
}
EUVIMED